Showing 5941-5950 of 6035 results for "".
- Ophthalmic OR Microscope Market to See More Than 6 Percent Growth over Next Five Yearshttps://modernod.com/news/ophthalmic-or-microscope-market-to-see-more-than-6-percent-growth-over-next-five-years/2480110/Market Scope expects the global ophthalmic operating room (OR) microscope market to grow at a healthy pace of more than 6 percent over the next 5 years, as 2018 revenues of $403 million climb to nearly $548 million by 2023. Revenues will rise most sharply in Latin America and other develop
- Ultrasonic Phaco Remains Dominant, but New Technologies Ready to Challengehttps://modernod.com/news/ultrasonic-phaco-remains-dominant-but-new-technologies-ready-to-challenge/2480114/Market Scope expects surgeons to perform nearly 18.5 million phaco procedures globally in 2018, and dedicated packs and accessories will make up more than 72 percent of the $1.6 billion in global cataract equipment revenues. Two factors will fuel modest growth in the cataract equipment mar
- Allergan Shareholders Urge Company to Overhaul Management Structure; Split Role of Chairman and CEOhttps://modernod.com/news/allergan-shareholders-urge-company-to-overhaul-management-structure-split-role-of-chairman-and-ceo/2480116/In a letter sent to Allergan’s board of directors on Tuesday, two company shareholders, Appaloosa Management and Senator Investment Group, called on the drugmaker to divide the roles of chief executive officer and chairman, currently held by Brent Saunders. The investors also urged Allergan
- Tobii and Lumus Bring Eye Tracking Technology to Augmented Reality Eyewearhttps://modernod.com/news/tobii-and-lumus-bring-eye-tracking-technology-to-augmented-reality-eyewear/2480121/At the Augmented World Expo (AWE) this week, Tobii announced that it is working with Lumus, a provider of transparent displays for augmented reality (AR), to incorporate eye tracking technology as part of the Lumus DK50 AR development kit.
- FDA Approves First Artificial Irishttps://modernod.com/news/fda-approves-first-artificial-iris/2480126/The FDA approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris is completely missing or damaged. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appear
- Trump Says Drug Companies to Unveil Price Cuts in Two Weekshttps://modernod.com/news/trump-says-drug-companies-to-unveil-price-cuts-in-two-weeks/2480129/Major pharmaceutical companies will announce “voluntary, massive” cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details, according to a
- Gene Therapies That Could Transform Diseases Get Easier FDA Pathhttps://modernod.com/news/gene-therapies-that-could-transform-diseases-get-easier-fda-path/2480144/New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the FDA to keep pace with one of biotechnology’s fastest-growing fields, according to a Bloomberg
- Tear Film Innovations Completes $8.5 Million Series B Fundinghttps://modernod.com/news/tear-film-innovations-completes-8-5-million-series-b-funding/2480145/Tear Film Innovations announced it has completed a $8.5 million Series B Preferred Stock funding round led by Visionary Ventures Fund LP and Bluestem Capital. “This successful funding round completes the capitalization for our growth strategy. We are currently making key hires to meet the
- Aerie Submits New Drug Application to FDA for Roclatanhttps://modernod.com/news/aerie-submits-new-drug-application-to-fda-for-roclatan/2480148/Aerie Pharmaceuticals announced the submission of its new drug application (NDA) to the FDA for Roclatan (netarsudil/latanoprost ophthalmic solution) .02%/.005%. Roclatan is a once-daily eye drop designed to reduce IOP in patients with glaucoma or ocular hypertension. It is a fixed dose combinati
- Genome Surgery for Eye Disease Moves Closer to Realityhttps://modernod.com/news/genome-surgery-for-eye-disease-moves-closer-to-reality/2480154/Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa. This is the first time researchers have successfully app